Tardive dyskinesia: clinical correlation with computed tomography in patients aged less than 60 years.

نویسندگان

  • M Brainin
  • T Reisner
  • J Zeitlhofer
چکیده

In a prevalence study of 335 psychiatric in-patients 49 patients (14.6%) with tardive dyskinesia were found. In view of the high prevalence of spontaneous dyskinetic syndromes in elderly patients only patients under 60 years were included (n = 21; mean age: 44.9). Clinical rating was performed with the AIMS-scale. CT measurements of ventricular enlargement and cortical atrophy were obtained. Tardive dyskinesia cases did not differ significantly from healthy controls, though some patients with severe dyskinesia showed signs of brain atrophy. These findings did not provide evidence to support neuropathological reports describing neuronal cell loss and midbrain gliosis in such patients. It is concluded that such structural brain changes in tardive dyskinesia patients are not detectable with present CT technology: they may either be due to concurrent aging processes or, in the case of younger patients, can be confirmed only by more functional methods of testing.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

An investigation on the relationship between risk factors and severity of tardive dyskinesia

The focus of most previous research concerning tardive dyskinesia has been on the impact of risk factors on the development( incidence) of this syndrome. In this paper, we report our results on the relationship between risk factors and the severity of tardive dyskinesia. A total of 33 patients diagnosed as tardive dyskinesia with no other medical illness studied: 21 males and 12 females with a ...

متن کامل

Tardive dyskinesia in older patients.

Neuroleptic-induced tardive dyskinesia, which often appears in middle-aged and older adults early in the course of treatment with low doses of conventional antipsychotics, is 5 to 6 times more prevalent in elderly than in younger patients. In addition to age, other risk factors for tardive dyskinesia include early extrapyramidal symptoms (EPS), cumulative amounts of neuroleptics, duration of ne...

متن کامل

Oxidative stress and tardive dyskinesia: role of natural antioxidants

Schizophrenia is a devastating psychiatric disorder that affects 1% of population worldwide. Neuroleptics are the major class of drugs used in the treatment of schizophrenia. Neuroleptics are associated with wide variety of extrapyramidal side effects such as akathesia, dystonia, neuroleptic malignant syndrome, Parkinsonism and tardive dyskinesia. tardive dyskinesia is a complex hyperkinetic sy...

متن کامل

Oxidative stress and tardive dyskinesia: role of natural antioxidants

Schizophrenia is a devastating psychiatric disorder that affects 1% of population worldwide. Neuroleptics are the major class of drugs used in the treatment of schizophrenia. Neuroleptics are associated with wide variety of extrapyramidal side effects such as akathesia, dystonia, neuroleptic malignant syndrome, Parkinsonism and tardive dyskinesia. tardive dyskinesia is a complex hyperkinetic sy...

متن کامل

Tardive dyskinesia associated with metoclopramide.

Eleven cases of tardive dyskinesia associated with metoclopramide have been reported to the Swedish Adverse Drug Reactions Advisory Committee from 1977 to 1981, 10 of which developed during the past three years. All patients were women, with a mean age of 76 years. Median duration of treatment before the onset of symptoms was 14 months. Calculated from total drug sales and prescription statisti...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of neurology, neurosurgery, and psychiatry

دوره 46 11  شماره 

صفحات  -

تاریخ انتشار 1983